ASCO GI 2023 | Importance of gaining real-world data following approvals of therapies

Sebastian Stintzing, MD, Charite University Hospital, Berlin, Germany, discusses the value of obtaining real-world evidence in clinical trials, which provides more confidence in the efficacy and associated toxicities of novel therapies. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.